Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Eisai Inc.
Merck Sharp & Dohme LLC
AstraZeneca
SWOG Cancer Research Network
Exelixis
Pfizer
Incyte Corporation
Bristol-Myers Squibb
Bristol-Myers Squibb
NRG Oncology
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Novartis
Bristol-Myers Squibb
Telix Pharmaceuticals (Innovations) Pty Limited
Hoffmann-La Roche
AVEO Pharmaceuticals, Inc.
Nektar Therapeutics
Hoffmann-La Roche
Bristol-Myers Squibb
Exelixis
Novartis
SFJ Pharmaceuticals, Inc.
National Cancer Institute (NCI)
Heidelberg Pharma AG
Alliance for Clinical Trials in Oncology
Heidelberg Pharma AG
Novartis
Hoffmann-La Roche
Pfizer
GlaxoSmithKline
Novartis
Bayer
INSYS Therapeutics Inc
Bayer
Pfizer
Novartis
Pfizer
Pfizer